ARVANA INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ARVANA INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $68.0K | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $68.3K | Jul 17, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $33.6K | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $41.6K | Jul 17, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($447.5K) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | ($1.32M) | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | ($151.4K) | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | ($12.12M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($477.6K) | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | $112.3K | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | $93.5K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($224.9K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($62.5K) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $92.7K | Apr 7, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($372.6K) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | ($486.9K) | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | ($165.8K) | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | ($102.7K) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($78.4K) | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | ($52.4K) | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | ($41.9K) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($39.0K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($40.0K) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($36.4K) | Apr 7, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($193.6K) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | ($168.0K) | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | ($133.3K) | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | ($33.6K) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($37.4K) | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | ($35.3K) | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | ($33.9K) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($29.1K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($44.0K) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($11.8K) | Apr 7, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $202.2K | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $216.5K | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $142.4K | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | $3.3K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $5.0K | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | $2.3K | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | $815 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.7K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $6.0K | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $53 | Apr 7, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.45M | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $1.18M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | $37.9K | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | $104.9K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.06M | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | $2.22M | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | $2.33M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.48M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $2.26M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $2.25M | Apr 7, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.25M) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | ($962.1K) | Jul 17, 2025 |
| FY2024 | Dec 31, 2022 | $104.5K | Jul 17, 2025 |
| FY2023 | Dec 31, 2021 | ($101.6K) | Apr 5, 2024 |
| FY2022 | Dec 31, 2020 | ($2.05M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2019 | ($2.21M) | Apr 21, 2022 |
| FY2020 | Dec 31, 2018 | ($2.33M) | Apr 9, 2021 |
| FY2020 | Dec 31, 2017 | ($2.48M) | Apr 9, 2021 |
| FY2020 | Dec 31, 2016 | ($2.25M) | Apr 9, 2021 |
| FY2020 | Dec 31, 2015 | ($2.25M) | Apr 9, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($38.03M) | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | ($37.56M) | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | ($36.24M) | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | ($36.09M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($23.97M) | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | ($23.49M) | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | ($23.61M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($23.70M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($23.48M) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($23.41M) | Apr 7, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $18.3K | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | $22.1K | Jul 17, 2025 |
| FY2020 | Dec 31, 2020 | $5.0K | Apr 9, 2021 |
| FY2020 | Dec 31, 2019 | $2.3K | Apr 9, 2021 |
| FY2020 | Dec 31, 2018 | $815 | Apr 9, 2021 |
| FY2019 | Dec 31, 2017 | $4.7K | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $6.0K | Apr 15, 2019 |
| FY2017 | Sep 30, 2016 | $53 | Apr 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.24M | Jul 17, 2025 |
| FY2023 | Dec 31, 2023 | $919.6K | Apr 5, 2024 |
| FY2020 | Nov 10, 2020 | $224.6K | Apr 9, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 107.85M | Jul 17, 2025 |
| FY2024 | Dec 31, 2023 | 107.84M | Jul 17, 2025 |
| FY2023 | Dec 31, 2022 | 107.84M | Apr 5, 2024 |
| FY2022 | Dec 31, 2021 | 34.15M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 4.61M | Apr 21, 2022 |
| FY2020 | Dec 31, 2019 | 1.03M | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | 1.03M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 1.03M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 1.03M | Apr 16, 2018 |
| FY2015 | Dec 31, 2015 | 885,130 | Apr 14, 2016 |